Prices of 22 essential drugs used for treatment of cancer, HIV, bacterial infections and malaria among others, have been capped by the government, reducing the cost in the range of 10-45 per cent.
Drug price regulator NPPA has also fixed the retail price of 13 formulations.
“NPPA has fixed/revised ceiling prices of 22 scheduled formulations of Schedule—I under Drugs (Price Control) Amendment Order, 2016 and retail price of 13 formulations under DPCO, 2013,” the National Pharmaceutical Pricing Authority (NPPA) said in a statement.
When contacted, NPPA Chairman Bhupendra Singh told PTI, “The prices have been reduced in the range of 10 to 45 per cent.
While the prices of some drugs have been reduced by 10 per cent, prices of others have been cut by up to 45 per cent.”
As stipulated under the Drugs (Prices Control) Order (DPCO) 2013, NPPA fixes ceiling price of essential medicines of Schedule I.
In respect of medicines not under price control, manufacturers are allowed to increase the maximum retail price by 10 per cent annually.
The calculation for essential drugs is based on the simple average of all medicines in a particular therapeutic segment with sales of more than 1 per cent.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.